Phenytoin is contraindicated in patients who are hypersensitive to Phenytoin or its inactive ingredients, or other hydantoins. Co-administration of Phenytoin with Delavirdine is contraindicated due to the potential for loss of virologic response and possible resistance to Delavirdine or to the class of non-nucleoside reverse transcriptase inhibitors.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
